XML 39 R19.htm IDEA: XBRL DOCUMENT
v3.22.2

Earnings Per Share Attributable to Cardinal Health, Inc. | 12 Months Ended
--- | ---
Jun. 30, 2022
Earnings Per Share [Abstract] |
Earnings Per Share Attributable to Cardinal Health, Inc. | 12. Earnings/(Loss) Per Share Attributable to Cardinal Health, Inc. The following table reconciles the computation of basic and diluted earnings per share attributable to Cardinal Health, Inc.:
(in millions, except per share amounts) | 2022 |  | 2021 |  | 2020
Net earnings/(loss) | $ | (932) |  |  | $ | 612 |  |  | $ | (3,693) |
Net earnings attributable to noncontrolling interest | (1) |  |  | (1) |  |  | (3) |
Net earnings/(loss) attributable to Cardinal Health, Inc. | $ | (933) |  |  | $ | 611 |  |  | $ | (3,696) |
Weighted-average common shares–basic | 279 |  |  | 292 |  |  | 293 |
Effect of dilutive securities: |  |  |  |  |
Employee stock options, restricted share units, and performance share units | — |  |  | 2 |  |  | — |
Weighted-average common shares–diluted | 279 |  |  | 294 |  |  | 293 |
Basic earnings/(loss) per common share attributable to Cardinal Health, Inc.: | $ | (3.35) |  |  | $ | 2.09 |  |  | $ | (12.61) |
Diluted earnings/(loss) per common share attributable to Cardinal Health, Inc.: | (3.35) |  |  | 2.08 |  |  | (12.61) |
The potentially dilutive employee stock options, restricted share units and performance share units that were anti-dilutive for fiscal 2022, 2021 and 2020 were 5 million, 3 million and 6 million, respectively. During fiscal 2022 and 2020, there were 1 million and 2 million potentially dilutive employee stock options, restricted share units and performance share units, respectively, not included in the computation of diluted loss per common share attributable to Cardinal Health, Inc. because their effect would be anti-dilutive as a result of the net loss for the fiscal years.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI https://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration